This week on Rule Breaker Investing, Motley Fool co-founder David Gardner is joined by Raj Sisodia and Nilima Bhat, ...

EQT Life Sciences has co-led a €51 million Series B financing in Exciva to support a Phase 2 clinical trial of Deraphan, a novel therapy for agitation associated with Alzheimer’s disease. The round, ...

The proposed Coordinate-Aware Feature Excitation (CAFE) module and Position-Aware Upsampling (Pos-Up) module both adhere to ...

From smoothies to soups, we tested over 20 blenders to find the ones worth keeping on your counter. These 8 made the cut.